Easton Pharmaceuticals, Inc. (OTCMKTS:EAPH) Gets Shortlisted Among Those Interested In Acquiring The A Hotel Resort And Casino In Loutraki, Greece

Easton Pharmaceuticals, Inc. (OTCMKTS:EAPH) has announced that they have been shortlisted to take part in the acquisition of the Hotel Resort and Casino Loutraki in Greece.

The resort has a private beach, 20 suites, and over 255 rooms, conference facility, wellness center, 8 restaurants as well as 1000 slot machines and 87 casino tables. It is located in Loutraki a town that is known for its therapeutic spas and natural springs.

Easton expanding their market segment

The acquisition is part of Easton Pharmaceuticals’ strategy to venture into lucrative market segments. The company has jointly been working with the consultancy firm and the bank charged with handling the sale of the hotel since last summer. The Loutraki Club Hotel Casino is among the 9 casinos that operate in Greece.

The opportunity to acquire the property culminates from the strong relationship between Easton’s CEO Mr. Evan Karras and some high ranking officials in the Greece government and influential business associates who are working to help bring the process closer for the consortium and Easton.

Mr. Karras is well known in Greece as he participated in the privatization of gaming in the country. He is conversant with the gaming industry in Greece as well as the property under consideration.

Discounted acquisition

The acquisition of the hotels has been discounted significantly and thus the cost offers a sunstanci8al upside to the company in the hospitality and gaming industry. It is equally designed for potential redevelopment into luxury condo vacation units.

Speaking on being listed in the shortlist, the Easton CEO, Evan Karras, indicated that making it to the shortlist was a significant step for the company. The CEO has already initiated numerous hospitality and gaming initiatives for Easton Pharmaceuticals as the company looks to venture into different market segments to enhance its growth and success.

He added that they expected to be among the hopeful lot for the opportunity to acquire the property. The company expects to close on an agreement close at almost the same time as the close of their recently announced hotel development venture discussions that are on progress in Toronto Canada.

By Emily Gibson

Emily is a graduate from Chicago with a B.A. in Business and Economics. Emily specializes in the biotech and health care sector, but also has a penchant for medical marijuana stocks, mining, retail, and automotive stocks, as well as personal finance and macroeconomic topics of interest.

Leave a Reply

Your email address will not be published. Required fields are marked *

Easton Pharmaceuticals Inc (OTCMKTS:EAPH) Announces It Is Moving Towards A Letter Of Intent With An AMPR Applicant Towards A Marijuana Cultivators / Growers License For Canada Easton Pharmaceuticals Inc (OTCMKTS:EAPH) Announces Development of a Blockchain and Cryptocurrency Initiative Easton Pharmaceuticals Inc (OTCMKTS:EAPH) Finalizes Acquisition Deal Of Herbs Of Kedem Easton Pharmaceuticals Inc (OTCMKTS:EAPH) Implements Expansion Plans

Pin It on Pinterest